Anti-IL31 ADCC Enhanced Antibody (BMS-981164) is an ADCC enhanced antibody produced by our Afuco™ platform. This is an anti-IL31 monoclonal antibody used as a potential treatment for atopic dermatitis, as well as for other diseases.
Figure 1 Human IL31 Recombinant Antibody (AFC-409CL) in WB
Western blot analysis of AFC-409CL was performed with IL31 Protein, Human, Recombinant (His Tag).
AFC-409CL incubation concentration: 2 ng/μL.
The secondary antibody: HRP-anti-human IgG
Lane 1: Reducing Antigen (0.1 μg)
Lane 2: Reducing Antigen (0.3 μg)
Lane 3: Reducing Antigen (0.6 μg)
Figure 2 Human IL31 Recombinant Antibody (AFC-409CL) in ELISA
ELISA analysis of AFC-409CL was performed by coating with IL31 Protein, Human, Recombinant (His Tag).
The secondary antibody: HRP-anti-human IgG
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1474-sdAb | Recombinant Anti-Human IL31 VHH Single Domain Antibody | ICC, ChiP, FC, FA | Llama VHH |
There are currently no Customer reviews or questions for AFC-409CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.